Anpario (LON:ANP) Hits New 52-Week High - Here's Why

Anpario plc (LON:ANP - Get Free Report) shares reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 398.50 ($5.00) and last traded at GBX 389 ($4.88), with a volume of 46046 shares traded. The stock had previously closed at GBX 385 ($4.83).

Analyst Ratings Changes

Several analysts have recently commented on ANP shares. Shore Capital reaffirmed a "house stock" rating on shares of Anpario in a report on Wednesday, September 11th. Canaccord Genuity Group boosted their target price on shares of Anpario from GBX 340 ($4.27) to GBX 370 ($4.64) and gave the company a "buy" rating in a research report on Wednesday, September 18th.

Anpario Stock Performance

The firm has a fifty day moving average of GBX 342.28 and a 200 day moving average of GBX 314.51. The company has a debt-to-equity ratio of 0.21, a current ratio of 6.15 and a quick ratio of 5.16. The stock has a market capitalization of £65.78 million, a price-to-earnings ratio of 2,161.11 and a beta of 0.58.

Insider Transactions at Anpario

In related news, insider Karen Prior sold 14,000 shares of the business's stock in a transaction on Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.77), for a total value of £53,200 ($66,750.31). Corporate insiders own 30.51% of the company's stock.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.